• publish

Listed@ASX 

Your go-to source for ASX IPO and listed company news, insights and analysis.

Sign up today

Listed@ASX Spring 2023 edition 

November 2023 

 

Welcome to the latest insights, news and profiles from the world of listed companies and IPOs. 

The ASX listings team has been hard at work, working with industry leaders and listed companies to bring you interesting profiles, trends and updates impacting the sector and those looking to list. 

Leah Weckert - leading a fresh vision for Coles

In our lead story, we speak to Leah Weckert, CEO of the Coles Group (ASX:COL) about her vision for the future of the iconic Australian Retailer. 

leah-weckert-coles

Video: Listed@ASX Interview: Getting to know Redox Limited ASX:RDX

Sasha Conoplia, Manager, Listings ASX spoke to Raimond Coneliano, CEO and Managing Director of Redox Limited, about the company's recent listing and plans for local and overseas markets. 

Read the transcript

Watching time: 7:12

Profiles and news

More insights 

Deterra

Standout year for listings on ASX 

Read More

new zealand

Growth in sole listings of New Zealand companies on ASX

Read More

cyber security

Cyber security round table: Protecting the perimeter

Read More

Insight: Australian Investor Study 2023 - Australians maintain fascination for investing

Read more 

Read more articles from the Listed@ASX archives

Read more 

For more information contact the ASX Listings team.

Cover story: Todd Barlow on the enduring nature of WHSP 

Read more

Australians maintain fascination for investing

Read more

Video: Getting to know Opthea (ASX:OPT) - interview with Megan Baldwin

Watch now

Get to know your cyber pulse 

Read now 

ESG reporting for small- and mid-cap companies

Read now 

Kiwi conquers US power poles

Read now 

Investors dig new mining investment model

Read now 

Incitec Pivot standing with global agriculture and mining

Read now

ASX capital markets 2022 - a year in review

Read now

Video: Getting to know newly-listed company, LGI

Watch now 

Straker: New Zealand language tech pioneer succeeds globally

Read more

Growth in sole listings of New Zealand companies on ASX

Read more 

ASX dual listing helps position TruScreen for long-term growth

Read more 

Listed@ASX goes digital

Read more 

Video: Getting to know Richard White of Wisetech Global 

Watch now 

Profile: Catapult - software over hardware  

Read now 

Case Study: Cluey Learning - Online learning comes of age   

Read now 

Profile: Volpara - The heart of the matter 

Read now 

Insight: Five megatrends shaping Australian and global agriculture

Read more

Profile: Lynch Group Holdings focused on blossoming flower market

Read more

New Zealand: Trans-Tasman agritech sector set to flourish

Read more

Video: Getting to know GrainCorp Limited (ASX: GNC)

Read more

Insight: Five megatrends shaping Australian and global agriculture

Read more

Cover story: Carrie Hurihanganui - In the slipstream

Read more

Profile: Opthea Limited - Looking ahead

Read more

Case study: Future Generation Investment Company - A new approach to philanthropy

Read more

ESG Round Table: It's the way you write your name

Read more

Profile: Doctor Care Anywhere - Aussie market attracts health innovators

Read more

Cyber Security Round Table: Protecting the perimeter

Read more

Australian Clinical Labs

Recently listed company, LGI (ASX: LGI) 

Giri Tenneti speaks to Dr. Jessica North of LGI 

Watch now

Australian Clinical Labs

Australian Clinical Labs (ASX: ACL) 

Giri Tenneti speaks to Australian Clinical Labs CEO, Melinda McGrath. 

Watch now

Australian Clinical Labs

Airtasker (ASX:ART) 

Giri Tenneti speaks to Airtasker Limited founder and CEO, Tim Fung. 

Watch now

Australian Clinical Labs

GrainCorp Limited (ASX: GNC)

Giri Tenneti speaks to Robert Spurway, CEO of GrainCorp Ltd

Watch now

Australian Clinical Labs

Wisetech Global (ASX: WTC)

Giri Tenneti speaks to Richard White, Founder and CEO of Wisetech Global

Watch now

Australian Clinical Labs

Clarity Pharmaceuticals (ASX:CU6)

James Posnett speaks to Dr. Alan Taylor, Executive Chairman of Clarity Pharmaceuticals

Watch now

Educational Webinars and Guides

Subscribe here to hear about upcoming educational events for listed companies and their advisors.

What's next?

For more information contact the ASX Listings team.

The views, opinions or recommendations of the author in this article are solely those of the author and do not in any way reflect the views, opinions, recommendations, of ASX Limited ABN 98 008 624 691 and its related bodies corporate (“ASX”). ASX makes no representation or warranty with respect to the accuracy, completeness or currency of the content. The content is for educational purposes only and does not constitute financial advice.  Independent advice should be obtained from an Australian financial services licensee before making investment decisions. To the extent permitted by law, ASX excludes all liability for any loss or damage arising in any way due to or in connection with the publication of this article, including by way of negligence.